Active Pharmaceutical Ingredient


Echo Pharmaceuticals is an established GMP supplier of Active Pharmaceutical Ingredients (API) for (medicinal) products and (clinical) development purposes and exports these all around the globe with Certificate of Analyses to companies with a valid license in line with regulatory agencies.



We supply Δ9-THC (delta9-tetrahydrocannabinol ≥ 98%) as Active Pharmaceutical Ingredient (API) for medicinal products and clinical trials, produced under cGMP guidelines.


We supply CBD (cannabidiol ≥ 98%) as ingredient for medical, nutraceutical, products and for clinical use produced under cGMP guidelines.

Terms and conditions

For more information read our terms and conditions or request a sales quote at

Contact us

Cannabis sativa L.

The Cannabis sativa L. is supplied by BMC, the Dutch government office for medicinal cannabis. The medicinal cannabis used is cultivated in a strictly controlled environment by Bedrocan, the only Dutch company officially contracted by the Ministry of Health for the growing and production of medicinal cannabis under Good Agricultural Practices.



Our Proces

Our products are consistently produced and controlled according to high quality standards and are available for R&D and GMP purposes.


Cannabis Sativa

Isolation of Cannabinoids

Purification ≥ 98%

Active Pharmaceutical Ingredient

Reference standards

Echo Pharmaceuticals is an established supplier of a wide range of high quality cannabinoid reference standards for research and development purposes all around the globe. Our cannabinoid standards are accompanied by a Certificate of Analysis that guarantees the high quality of the products.

Image Image Image Image Image

Learn More about reference standards



Our products are consistently produced and controlled according to the high quality standards of GMP (Good Manufacturing Practice).